{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:16:48Z","timestamp":1772086608000,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,5,5]],"date-time":"2011-05-05T00:00:00Z","timestamp":1304553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,5,5]],"date-time":"2011-05-05T00:00:00Z","timestamp":1304553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1038\/gt.2011.61","type":"journal-article","created":{"date-parts":[[2011,5,5]],"date-time":"2011-05-05T10:20:42Z","timestamp":1304590842000},"page":"1098-1102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1"],"prefix":"10.1038","volume":"18","author":[{"given":"S J","family":"Advani","sequence":"first","affiliation":[]},{"given":"J M","family":"Markert","sequence":"additional","affiliation":[]},{"given":"R F","family":"Sood","sequence":"additional","affiliation":[]},{"given":"S","family":"Samuel","sequence":"additional","affiliation":[]},{"given":"G Y","family":"Gillespie","sequence":"additional","affiliation":[]},{"given":"M Y","family":"Shao","sequence":"additional","affiliation":[]},{"given":"B","family":"Roizman","sequence":"additional","affiliation":[]},{"given":"R R","family":"Weichselbaum","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,5,5]]},"reference":[{"key":"BFgt201161_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 459\u2013466.","journal-title":"Lancet Oncol"},{"key":"BFgt201161_CR2","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/0360-3016(89)90941-3","volume":"16","author":"KE Wallner","year":"1989","unstructured":"Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG . Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989; 16: 1405\u20131409.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFgt201161_CR3","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1126\/science.1851332","volume":"252","author":"RL Martuza","year":"1991","unstructured":"Martuza RL, Malick A, Markert JM, Ruffner KL, Coen DM . Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 1991; 252: 854\u2013856.","journal-title":"Science"},{"key":"BFgt201161_CR4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/sj.gt.3301205","volume":"7","author":"JM Markert","year":"2000","unstructured":"Markert JM, Medlock MD, Rabkin SD, Gillespie GY, Todo T, Hunter WD et al. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Therapy 2000; 7: 867\u2013874.","journal-title":"Gene Therapy"},{"key":"BFgt201161_CR5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/sj.gt.3301184","volume":"7","author":"R Rampling","year":"2000","unstructured":"Rampling R, Cruickshank G, Papanastassiou V, Nicoll J, Hadley D, Brennan D et al. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Therapy 2000; 7: 859\u2013866.","journal-title":"Gene Therapy"},{"key":"BFgt201161_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/mt.2008.228","volume":"17","author":"JM Markert","year":"2009","unstructured":"Markert JM, Liechty PG, Wang W, Gaston S, Braz E, Karrasch M et al. Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM. Mol Ther 2009; 17: 199\u2013207.","journal-title":"Mol Ther"},{"key":"BFgt201161_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.nurt.2009.04.011","volume":"6","author":"JN Parker","year":"2009","unstructured":"Parker JN, Bauer DF, Cody JJ, Markert JM . Oncolytic viral therapy for malignant glioma. Neurotherapeutics 2009; 6: 558\u2013569.","journal-title":"Neurotherapeutics"},{"key":"BFgt201161_CR8","doi-asserted-by":"publisher","first-page":"11307","DOI":"10.1073\/pnas.93.21.11307","volume":"93","author":"B Roizman","year":"1996","unstructured":"Roizman B . The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors. Proc Natl Acad Sci USA 1996; 93: 11307\u201311312.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201161_CR9","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nrc948","volume":"2","author":"EA Chiocca","year":"2002","unstructured":"Chiocca EA . Oncolytic viruses. Nat Rev Cancer 2002; 2: 938\u2013950.","journal-title":"Nat Rev Cancer"},{"key":"BFgt201161_CR10","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1126\/science.2173860","volume":"250","author":"J Chou","year":"1990","unstructured":"Chou J, Roizman B . Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science 1990; 250: 1262\u20131266.","journal-title":"Science"},{"key":"BFgt201161_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/sj.gt.3300546","volume":"5","author":"SJ Advani","year":"1998","unstructured":"Advani SJ, Sibley GS, Song PY, Hallahan DE, Kataoka Y, Roizman B et al. Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors. Gene Therapy 1998; 5: 160\u2013165.","journal-title":"Gene Therapy"},{"key":"BFgt201161_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/sj.cgt.7700835","volume":"12","author":"J Dilley","year":"2005","unstructured":"Dilley J, Reddy S, Ko D, Nguyen N, Rojas G, Working P et al. Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity. Cancer Gene Ther 2005; 12: 715\u2013722.","journal-title":"Cancer Gene Ther"},{"key":"BFgt201161_CR13","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1158\/1078-0432.CCR-07-1306","volume":"12","author":"C Liu","year":"2007","unstructured":"Liu C, Sarkaria JN, Petell CA, Paraskevakou G, Zollman PJ, Schroeder M et al. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme. Clin Cancer Res 2007; 12: 7155\u20137165.","journal-title":"Clin Cancer Res"},{"key":"BFgt201161_CR14","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1158\/1078-0432.CCR-07-1400","volume":"14","author":"K Twigger","year":"2008","unstructured":"Twigger K, Vidal L, White CL, De Bono JS, Bhide S, Coffey M et al. Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy. Clin Cancer Res 2008; 14: 912\u2013923.","journal-title":"Clin Cancer Res"},{"key":"BFgt201161_CR15","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1158\/1078-0432.CCR-07-4134","volume":"14","author":"NM Alajez","year":"2008","unstructured":"Alajez NM, Mocanu JD, Shi W, Chia MC, Breitbach CJ, Hui AB et al. Efficacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinoma. Clin Cancer Res 2008; 14: 4891\u20134897.","journal-title":"Clin Cancer Res"},{"key":"BFgt201161_CR16","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1158\/0008-5472.CAN-04-4526","volume":"65","author":"J Qian","year":"2005","unstructured":"Qian J, Yang J, Dragovic AF, Abu-Isa E, Lawrence TS, Zhang M . Ionizing radiation-induced adenovirus infection is mediated by dynamin 2. Cancer Res 2005; 65: 5493\u20135497.","journal-title":"Cancer Res"},{"key":"BFgt201161_CR17","first-page":"1517","volume":"5","author":"JD Bradley","year":"1999","unstructured":"Bradley JD, Kataoka Y, Advani S, Chung SM, Arani RB, Gillespie GY et al. Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus. Clin Cancer Res 1999; 5: 1517\u20131522.","journal-title":"Clin Cancer Res"},{"key":"BFgt201161_CR18","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1158\/0008-5472.CAN-04-3793","volume":"65","author":"CG Hadjipanayis","year":"2005","unstructured":"Hadjipanayis CG, DeLuca NA . Inhibition of DNA repair by a herpes simplex virus vector enhances the radiosensitivity of human glioblastoma cells. Cancer Res 2005; 65: 5310\u20135316.","journal-title":"Cancer Res"},{"key":"BFgt201161_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1067\/msy.2002.125715","volume":"132","author":"SF Stanziale","year":"2002","unstructured":"Stanziale SF, Petrowsky H, Joe JK, Roberts GD, Zager JS, Gusani NJ et al. Ionizing radiation potentiates the antitumor efficacy of oncolytic herpes simplex virus G207 by upregulating ribonucleotide reductase. Surgery 2002; 132: 353\u2013359.","journal-title":"Surgery"},{"key":"BFgt201161_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1245\/s10434-006-9127-4","volume":"14","author":"PS Adusumilli","year":"2007","unstructured":"Adusumilli PS, Chan MK, Hezel M, Yu Z, Stiles BM, Chou TC et al. Radiation-induced cellular DNA damage repair response enhances viral gene therapy efficacy in the treatment of malignant pleural mesothelioma. Ann Surg Oncol 2007; 14: 258\u2013269.","journal-title":"Ann Surg Oncol"},{"key":"BFgt201161_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.athoracsur.2005.01.048","volume":"80","author":"PS Adusumilli","year":"2005","unstructured":"Adusumilli PS, Stiles BM, Chan MK, Chou TC, Wong RJ, Rusch VW et al. Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer. Ann Thorac Surg 2005; 80: 409\u2013416.","journal-title":"Ann Thorac Surg"},{"key":"BFgt201161_CR22","doi-asserted-by":"publisher","first-page":"9479","DOI":"10.1158\/0008-5472.CAN-05-1927","volume":"65","author":"JJ Mezhir","year":"2005","unstructured":"Mezhir JJ, Advani SJ, Smith KD, Darga TE, Poon AP, Schmidt H et al. Ionizing radiation activates late herpes simplex virus 1 promoters via the p38 pathway in tumors treated with oncolytic viruses. Cancer Res 2005; 65: 9479\u20139484.","journal-title":"Cancer Res"},{"key":"BFgt201161_CR23","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ijrobp.2006.06.034","volume":"66","author":"SJ Advani","year":"2006","unstructured":"Advani SJ, Mezhir JJ, Roizman B, Weichselbaum RR . ReVOLT: radiation-enhanced viral oncolytic therapy. Int J Radiat Oncol Biol Phys 2006; 66: 637\u2013646.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFgt201161_CR24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/jvi.70.1.84-90.1996","volume":"70","author":"B He","year":"1996","unstructured":"He B, Chou J, Liebermann DA, Hoffman B, Roizman B . The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. J Virol 1996; 70: 84\u201390.","journal-title":"J Virol"},{"key":"BFgt201161_CR25","doi-asserted-by":"publisher","first-page":"13731","DOI":"10.1074\/jbc.272.21.13731","volume":"272","author":"MC Hollander","year":"1997","unstructured":"Hollander MC, Zhan Q, Bae I, Fornace Jr AJ . Mammalian GADD34, an apoptosis- and DNA damage-inducible gene. J Biol Chem 1997; 272: 13731\u201313737.","journal-title":"J Biol Chem"},{"key":"BFgt201161_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0360-3016(98)00416-7","volume":"43","author":"RS Hudes","year":"1999","unstructured":"Hudes RS, Corn BW, Werner-Wasik M, Andrews D, Rosenstock J, Thoron L et al. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys 1999; 43: 293\u2013298.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFgt201161_CR27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11060-009-0034-y","volume":"97","author":"RG Torcuator","year":"2010","unstructured":"Torcuator RG, Thind R, Patel M, Mohan YS, Anderson J, Doyle T et al. The role of salvage reirradiation for malignant gliomas that progress on bevacizumab. J Neurooncol 2010; 97: 401\u2013407.","journal-title":"J Neurooncol"},{"key":"BFgt201161_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3109\/09553000903419338","volume":"86","author":"C Liu","year":"2010","unstructured":"Liu C, Zhang Y, Liu MM, Zhou H, Chowdhury W, Lupold SE et al. Evaluation of low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy in prostate cancer. Int J Radiat Biol 2010; 86: 220\u2013229.","journal-title":"Int J Radiat Biol"},{"key":"BFgt201161_CR29","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/mt.sj.6300120","volume":"15","author":"SO Freytag","year":"2007","unstructured":"Freytag SO, Movsas B, Aref I, Stricker H, Peabody J, Pegg J et al. Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer. Mol Ther 2007; 15: 1016\u20131023.","journal-title":"Mol Ther"},{"key":"BFgt201161_CR30","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1158\/1078-0432.CCR-10-0054","volume":"16","author":"KJ Harrington","year":"2010","unstructured":"Harrington KJ, Karapanagiotou EM, Roulstone V, Twigger KR, White CL, Vidal L et al. Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers. Clin Cancer Res 2010; 16: 3067\u20133077.","journal-title":"Clin Cancer Res"},{"key":"BFgt201161_CR31","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1158\/1078-0432.CCR-10-0196","volume":"16","author":"KJ Harrington","year":"2010","unstructured":"Harrington KJ, Hingorani M, Tanay MA, Hickey J, Bhide SA, Clarke PM et al. Phase I\/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III\/IV squamous cell cancer of the head and neck. Clin Cancer Res 2010; 16: 4005\u20134015.","journal-title":"Clin Cancer Res"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201161","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T10:17:31Z","timestamp":1648549051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,5]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["BFgt201161"],"URL":"https:\/\/doi.org\/10.1038\/gt.2011.61","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,5]]},"assertion":[{"value":"16 September 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}